Skip to main content

Hemolytic-Uremic Syndrome clinical trials at University of California Health

2 research studies open to eligible people

Showing trials for
  • A Study of Experimental Drug Crovalimab in Atypical Hemolytic Uremic Syndrome

    “Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”

    open to eligible people ages 12 years and up

    This study aims to evaluate the efficacy and safety of crovalimab in adult and adolescent participants with aHUS.

    at UC Davis UC Irvine UCSF

  • Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection

    open to eligible people ages 9 months to 21 years

    The objective of this study is to determine if early high volume intravenous fluid administration (hyperhydration) may be effective in mitigating or preventing complications of shiga toxin-producing E. coli (STEC) infection in children and adolescents when compared with traditional approaches (conservative fluid management).

    at UC Davis UCSD

Last updated: